EN

Atsumi & Sakai
Yukiko Mitsuhashi
Contact
Print

Yukiko Mitsuhashi

Senior Partner

Main Practices
Asset Management and Investment Funds / Labor and Employment Law / Corporate Governance / General Corporate Legal Affairs / Advertising and Marketing / Real Estate Financing and REITs / Data Protection, Privacy, and Cybersecurity / Pharmaceuticals, Cosmetics, and Medical Devices / Digital Health / Medical IP and Licensing / Privacy and Big Data / DX Governance, E-Contracts, and Service Digitalization / Data Utilization
Languages
Japanese / English
Office
Tokyo
Contact

Overview

Publications & Seminars

Awards

Admitted

Japan (2000)

Bar Association

Daini Tokyo Bar Association

Education

Kyoto University Faculty of Letters (B.A., 1989)
The Legal Training and Research Institute of the Supreme Court of Japan

Background

Central Japan Railway Company (April 1989-December 1996)
Blakemore & Mitsuki Law Office (November 2000-October 2002)
Ashurst Tokyo Law Office (November 2002-December 2009)
City-Yuwa Partners (January 2010-July 2020)
Outside Director, AOI Pro. Inc. (June 2015-March 2022)
Outside Director, PUNCH INDUSTRY CO., LTD (June 2016-June 2022, Chair of the Board of Directors: June 2018-June 2022）
Compliance Officer, GLP Japan Advisors Inc. (February 2017-June 2018)

External Corporate Auditor, Archem Inc. (September 2022- )

External Corporate Auditor, ANA Holdings Inc. (July 2023- )

Member

Advisor to Japan Pharmaceutical Industry Legal Affairs Association, Regulatory Law Group

The Japanese Association of International Business Law

Publications

  • Getting the Deal Through - Pharma & Medical Device Regulation 2024, Japan Chapter, Law Business Research Ltd. (2023) [Co-author]

  • Getting the Deal Through - Pharma & Medical Device Regulation 2023, Japan Chapter, Law Business Research Ltd. (2022) [Co-author]

  • Expert essay “Legal Thinking Ability as a Business Tool,” Legal Mind January Issue (2021)

Seminars

  • “The Act on Protection of Personal Information－Topics Related to Law Amendment（Based on ‘Interim Summary’）,” hosted by International Pharmaceutical & Medical Device Privacy Consortium (IPMPC), November 12, 2019